Back to top
more

Direxion Daily S&P Biotech Bear 3X Shares: (LABD)

(Real Time Quote from BATS) As of Apr 23, 2024 02:10 PM ET

$9.67 USD

9.67
15,321,002

-0.72 (-6.93%)

Volume: 15,321,002

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

ETF Quote Details

Previous Close 10.39
Open 10.23
Bid 9.67
Ask 9.68
Day Low-High 9.49-10.26
52wk Low-High 5.72-29.92
Volume 15,244,077
NAV (month end) 7.26
Premium (+)/Discount (-) (month end)+3.13

Zacks Premium Research for LABD

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

 NA
ETF Risk

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

High

ETF Expense Ratio

Expense Ratio 1.09%
Dividend (Yield) $0.44 (4.26%)
Issuer DIREXION

Benchmark for LABD

S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX

The S&P Biotechnology Select Industry Index is designed to measure the performance of a sub-industry or group of sub-industries determined based on the Global Industry Classification Standards (GICS).

Fund Summary for LABD

DIREXION DAILY SP BIOTECH BEAR 3X SHARES

The Direxion Daily S&P Biotech Bear 3X Shares fund seeks daily investment results, before fees and expenses, of 300% of the inverse of the performance of the S&P Biotechnology Select Industry Index.